Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement

Exclusion Criteria

• •1. A person who has received anticoagulant or antiplatelet agent within 2 weeks before application of medical device for clinical trial or Those who need to be administered until two weeks after application (However, low-dose aspirin (300 mg / day or less) is permitted.
• •2. A person who has received a vitamin E preparation, NSAID preparation within 1 week of application of medical device for clinical trial or Those who need to take medicine until 1 week after application
• •3. Those who have a history of bleeding in past or present time
• •4. Persons who are adversely affected by excessive penis enlargement, which may adversely affect the operation of the medical device
• •5. Those who have undergone penis enlargement surgery (fat, alternative dermatologic transplantation) in the past (except for hyaluronic acid or collagen. Two years after transplantation and extension of the penis, such as suprapubic fat preparation and suspension ligament resection In the case of surgery, it is allowed.)
• •6. Peyronie's disease of the penis (Peyronie's disease) malformation
• •7. Anaphylaxis or severe allergic symptoms.